Nosocomial and non-nosocomial Clostridium difficile infections hospitalised patients in Belgium - compulsory surveillance data from 2008 to 2010

Eurosurveillance

Volumn 16, Issue 43, 2011, Pages

  Viseur, N ^a   Lambert, M L ^a   Delmee M ^b   van Broeck, J ^b   Catry, B ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; RNA 23S; SPACER DNA;

ADULT; AGE; AGED; ARTICLE; BELGIUM; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY LIVING; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; FEMALE; GENDER; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NURSING HOME; POLYMERASE CHAIN REACTION; PSEUDOMEMBRANOUS COLITIS; RIBOTYPING;

EID: 80455128242     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466-72.
2. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2008;14(6):929-31.
3. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill. 2008;13(31):pii=18942. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18942
4. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079-84.
5. Zaiß NH, Witte W, Nübel U. Fluoroquinolone resistance and Clostridium difficile, Germany. Emerg Infect Dis. 2010;16(4):675-7.
6. Gutierrez I, Lambert ML. Trends in mortality and morbidity related to Clostridium difficile infections, Belgium 1998-2007. Brussels: Scientific Institute for Public Health; April 2010. ISSN: D/2010/2505/18. Available from: http://www.nsih.be/download/CDIF/CDI_trends_mortality_morbidity_final_report_June_2010.pdf
7. Joseph R, Demeyer D, Vanrenterghem D, van den Berg R, Kuijper E, Delmee M. First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill. 2005;10(42):pii=2815. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2815
8. Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-asssociated disease in populations previously at low risk--four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54(47):1201-5.
9. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile--Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(13):340-3.
10. Kutty PK, Woods CW, Sena AC, Benoit SR, Naggie S, Frederick J, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010;16(2):197-204.
11. McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a veterans administration health care system. Clin Infect Dis. 2007;45(9):1141-51.
12. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62(2):388-96.
13. Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J. 2008;27(12):1111-13.
14. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. Epidemiological Features of Clostridium difficile-Associated Disease Among Inpatients at Children's Hospitals in the United States, 2001-2006. Pediatrics. 2008;122(6):1266-70.
15. Rouphael NG, O'Donnell JA, Bhatnagar J, Lewis F, Polgreen PM, Beekmann S, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol. 2008;198(6):635-6.
16. Scientific Institute for Public Health (ISP). Surveillance des infections à Clostridium difficile. Protocole. [Surveillance of Clostridium difficile infections. Protocol]. Version 4.0. Brussels: ISP; 2010. French. Available from: http://www.nsih.be/surv_cdif/download_fr.asp
17. Viseur N, Lambert ML. Epidémiologie des infections à Clostridium difficile en Belgique; rapport 2011. [Epidemiology of Clostidium difficile infections in Belgium; report 2011]. Brussels: Scienific Institute for Public Health; 2011. ISSN-version online: 2034-4562. French. Available from: http://www.nsih.be/download/CDIF/CDIF-AR-2011-FR.pdf
18. Bauer MP, Kuijper EJ, van Dissel JT; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15(12):1067-79.
19. Barbut F, Mario N, Delmée M, Gozlan J, Petit JC. Genomic fingerprinting of Clostridium difficile isolates by using a random amplified polymorphic DNA (RAPD) assay. FEMS Microbiol Lett. 1993;114(2):161-6.
20. The NHS Confederation. Variation in healthcare: does it matter and can anything be done? London: NHS Confederation; 2004. Available from: http://www.nhsconfed.org/Publications/Documents/Variation%20in%20healthcare.pdf
21. Coignard B, Eckert C, Rahib D, Hébert M, Boussat S, Jarno P, et al. Caractéristiques épidémiologiques et microbiologiques des infections à Clostridium difficile en France: résultats de l'étude ICD-RAISIN 2009. [Epidemiological and microbiological characteristics of Clostridium difficile infections in France: reults of the ICD-RAISIN 2009 study]. Powerpoint presentation. XXIth congress of the de la SFHH. 3 June 2010; Bordeaux, France. French. Available from: http://www.cleanis.fr/docs/news/fr/icd-en-france-en-2009_127840418738166800.pdf
22. Hensgens MP, Goorhuis A, Notermans DW, van Benthem BH, Kuijper EJ. Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill. 2009;14(45):pii=19402. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19402
23. Gastmeier P, Weitzel-Kage D, Behnke M, Eckmanns T. Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrob Agents. 2009;33 Suppl 1:S19-S23.
24. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73.
25. Health Protection Agency (HPA). Results of the mandatory Clostridium difficile reporting scheme by acute Trust in UK (2007-2010). London: HPA. [Accessed June 2011]. Available from: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1195733750761
26. Surveillance data on Clostridium difficile Infection in Québec hospitals. ISBN no: 2-550-45949-0. Québec: Ministère de la Santé et des Services sociaux (MSSS). [Accessed June 2011]. French. Available from: http://msssa4.msss.gouv.qc.ca/en/document/publication.nsf/fb143c75e0c27b69852566aa0064b01c/9ee11991af5fce358525753c00650c88?OpenDocument